U.S. Markets closed

iCo Therapeutics Inc. (ICO.V)


TSXV - TSXV Delayed Price. Currency in CAD
Add to watchlist
0.055+0.00 (+10.00%)
At close: 12:35PM EDT
People also watch
KNE.VBTI.VATE.VDMA.VEKG.V
Full screen
Previous Close0.050
Open0.050
Bid0.050 x
Ask0.055 x
Day's Range0.050 - 0.055
52 Week Range0.030 - 0.090
Volume114,000
Avg. Volume418,310
Market Cap4.65M
Beta1.91
PE Ratio (TTM)-4.58
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile7 days ago

    iCo Therapeutics Announces Pre IND meeting for Novel Glaucoma Asset

    Vancouver, British Columbia--(Newsfile Corp. - June 15, 2017) - iCo Therapeutics (TSXV: ICO) (OTCQB: ICOTF) ("iCo" or "the Company"), today reported it will hold a pre IND meeting with the Division of Transplantation and Ophthalmology, US Food and Drug Administration (FDA) on June 21st, 2017. Discussions will focus on a proprietary dual action glaucoma asset with a novel mechanism of action that reduces intraocular pressure (IOP). The target is validated by literature and a ...

  • Newsfile10 days ago

    iCo Therapeutics Announces Positive Oral Amphotericin Study

    Vancouver, British Columbia--(Newsfile Corp. - June 12, 2017) - iCo Therapeutics (TSXV: ICO) (OTCQB: ICOTF) ("iCo" or "the Company"), today reported the successful conclusion of pre-clinical studies involving its lead oral Amphotericin B candidate, including compelling safety data from its pivotal 14 day GLP (Good Laboratory Practices compliant) toxicology study.Data from its IND enabling 14 day GLP study conducted in Toronto, Ontario facilities revealed that oral administration of Amphotericin B at a dose levels of ...

  • Associated Press29 days ago

    Ico Therapeutics posts 1Q loss

    The Vancouver, British Columbia-based company said it had a loss of less than 1 cent on a per-share basis. In the final minutes of trading on Wednesday, the company's shares hit 3 cents. A year ago, they ...